This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| Rolls-Royce Holdings PLC | 297.9 | 3.0% |
| Jd Sports Fashion PLC | 171.8 | 2.9% |
| Hargreaves Lansdown PLC | 764.6 | 2.2% |
| Intercontinental Hotels Group PLC | 6,956.0 | 1.8% |
| Ashtead Group PLC | 5,111.6 | 1.6% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| Glencore PLC | 440.4 | -3.7% |
| Endeavour Mining PLC | 1,696.0 | -3.6% |
| Centrica PLC | 144.3 | -3.5% |
| International Consolidated Airlines Group S.A. | 155.5 | -1.8% |
| Standard Chartered PLC | 648.0 | -1.8% |
| Major World Indices | Price | % Chg | 1 YEAR |
| UK 100 INDEX | 7,551 | -0.1% | 0.5% |
| DOW JONES INDUS. AVG | 36,358 | 0.3% | 8.6% |
| DAX INDEX | 16,792 | 0.2% | 16.7% |
| NIKKEI 225 | 32,792 | 1.5% | 17.8% |
| S&P/ASX 200 INDEX | 7,199 | 0.1% | 0.3% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 70.97 | -0.37% |
| Brent Crude (ICE) | USD/bbl. | 75.64 | -0.26% |
| Gold Spot | USD/t oz. | 1,983 | -1.1% |
| Copper (Comex) | USd/lb. | 379 | -1.0% |
Click graph to enlarge
The UK 100 called to open +21 points at 7,565. The UK 100 is expected to open higher on Tuesday following gains in the US on Monday and some good news for the Bank of England this morning after figures from the Office for National Statistics showed a larger than expected drop in wage inflation. Average weekly earnings excluding bonuses rose by 7.3% in the three months through October, compared to the expectation of 7.4% and last month’s 7.7% growth. On Wall Street, the Dow Jones closed 157.06 points higher, 0.4%, at 36,404.93. The S&P rose 18.07 points, or 0.4%, at 4,622.44, and the Nasdaq advanced 28.51 points, or 0.2%, at 14,432.49. Later today, US inflation figures will be released while the two-day FOMC meeting kicks off.
AstraZeneca are to buy Icosavax for $1.1bn, which will close in Q1 2024.
Chemring Group report a FY23 pretax profit of £44.1m, down from £47.9m YoY. They propose a final dividend per share of 4.6p, up 21% YoY, with total dividend being 6.9p. Their focus continues to be on expanding the group’s product and they expect their FY23 momentum to continue into FY24.
GSK says Japan health ministry accepts Arexvy application to prevent RSV disease.
Telecom stocks (BT Group & Vodafone): Ofcom proposes ban on inflation-linked mid-contract price rises by telecom firms and says phone, broadband and pay TV providers must tell customers upfront about price rises.
JP Morgan Adds Segro to ‘Analyst Focus List’ (5 Buys / 6 Holds / 0 Sells)
JP Morgan Upgrades Rio Tinto to Overweight from Neutral (7 Buys / 8 Holds / 0 Sells)
Macquarie Upgrades Virgin Money to Outperform (8 Buys / 8 Holds / 1 Sell)
UK
Chemring Group
US
None
UK
None
US
Adobe Systems Inc
UK Average Earnings Excluding Bonus
UK Claimant Count Change
UK Employment Change
UK ILO Unemployment Rate
EU ZEW Survey – Economic Sentiment
German ZEW Survey – Current Situation
German ZEW Survey – Economic Sentiment
US Consumer Price Index
US Monthly Budget Statement
Japanese Tankan Large Manufacturing Index
UK 100 companies going ex-dividend on 14th December 2023:
Smith (DS)
Associated British Foods
Burberry Group
UK 250 companies going ex-dividend on 14th December 2023:
Sirius Real Estate
Redde Northgate
TR Property Investment Trust
Tritax EuroBox GBP
MITIE Group
Balanced Commercial Property Trust
Cranswick
discoverIE Group
Baltic Classifieds Group
Personal Assets Trust
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.